☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
AstraZeneca and Merck's Lynparza (olaparib) Receive EU's Approval as a Monotherapy to Treat Germline BRCA-Mutated HER2-Negative Ad...
April 10, 2019
Alkermes' Reports Results of Aristada (aripiprazole lauroxil) and Invega Sustenna (paliperidone palmitate) in P-IIIb ALPINE Study...
April 10, 2019
Shanghai Fosun Signs an Exclusive License Agreement with ReNeuron for its CTX and hRPC Cell Therapy in China
April 10, 2019
Amgen's Evenity (romosozumab-aqqg) Receives FDA's Approval for Osteoporosis in Postmenopausal Women at High Risk for Fracture
April 10, 2019
Xinhua Healthcare Signs an Exclusive License Agreement with ArcDia for its mariPOC Technology in China
April 10, 2019
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions